Clinical Trials Browser

Completed × INDUSTRY × Observational × Clear all

NCT04529122 2026-05-27

A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test

Other solid neoplasm

Solid Tumours

NCT04813627 2026-05-22

Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

Gastrointestinal

Colorectal Neoplasms

NCT06714370 2026-05-20

REVEAL

Brain Neoplasms, Lymphoma, Rare Diseases

NCT06255041 2026-05-15

Detection of Cancer in Breath Samples by Trained Detection Dogs

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06790420 2026-05-15

RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study

2,703 enrolled 13 charts

Infections, Lymphoma

NCT07238322 2026-05-15

[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes

Brain Neoplasms, Glioma

NCT06472778 2026-05-08

A Real-world Study in Participants With Smoldering Multiple Myeloma

Smoldering Multiple Myeloma

NCT06075758 2026-05-06

A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer

Breast Neoplasms

NCT04727723 2026-05-04

REAL-LU

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

NCT06152276 2026-05-04

SH-SOC23

Gastrointestinal

Colorectal Neoplasms

NCT06170619 2026-04-29

OCCLUDE

Hemorrhage

NCT04981795 2026-04-27

realMIND

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT04943380 2026-04-24

DRIVE

Carcinoma, Transitional Cell, Hematuria

NCT03494660 2026-04-21

SCP Hip Outcomes Study

77 enrolled 34 charts

Bone Cysts, Hip Dislocation, Fractures, Stress, Femoracetabular Impingement

NCT05153187 2026-04-21

Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan

1,170 enrolled 16 charts

Breast Neoplasms

NCT02695121 2026-04-17

Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment

2,133,575 enrolled

BreastGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms

NCT07101874 2026-04-17

ARCBile

Gastrointestinal

Biliary Tract Neoplasms

NCT04998864 2026-04-16

Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients

Glioblastoma, Glioma

NCT04181333 2026-04-14

Safety and Efficacy of Trastuzumab BS

8 enrolled 8 charts

Gastrointestinal

Stomach Neoplasms

NCT05826366 2026-04-14

Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

Carcinoma, Non-Small-Cell Lung

NCT07526961 2026-04-14

Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland

Carcinoma, Non-Small-Cell Lung

NCT05021562 2026-04-13

A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice

Ovarian Neoplasms

NCT05461430 2026-04-13

TraveraRTGx

BreastDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Anus Neoplasms, Appendiceal Neoplasms, Ascites, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lung Neoplasms, Melanoma, Mesothelioma, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Penile Neoplasms, Stomach Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Small Cell, Carcinoma, Pancreatic Ductal, Gastrointestinal Stromal Tumors

NCT07512063 2026-04-13

A Study of Real-World Treatment Patterns and Outcomes Among HR+/HER2- Metastatic Breast Cancer Patients Treated With First-Line CDK4/6 Inhibitors

Breast Neoplasms

NCT05399329 2026-04-09

Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan

Breast Neoplasms

NCT06973161 2026-04-08

ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

GastrointestinalGenitourinaryGynecologicThoracic

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07143513 2026-04-07

Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients

Carcinoma, Non-Small-Cell Lung

NCT05478590 2026-04-03

A Study to Describe Treatment Patterns of Advanced Breast Cancer in Poland in the Real-world Data Setting

Breast Neoplasms

NCT04822350 2026-04-02

AVENANCE

596 enrolled 43 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06962969 2026-04-02

A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database

Breast Neoplasms

NCT04943497 2026-04-01

PROSPERITY

Breast Neoplasms

NCT07498413 2026-04-01

ROTOR

218,677 enrolled

Breast Neoplasms, Disease Progression

NCT07477756 2026-03-19

A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients

Prostatic Neoplasms

NCT04066504 2026-03-18

NISSO

Carcinoma, Basal Cell

NCT06428799 2026-03-18

EMBLEDDA-MMG

Breast Neoplasms

NCT06221397 2026-03-16

LEGIT_MC_EVCDA

105 enrolled 15 charts

Disease, Melanoma

NCT05677308 2026-03-13

LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)

Breast Neoplasms

NCT05913440 2026-03-12

HER2-low Unresectable and/or Metastatic Breast Cancer in Russia

Breast Neoplasms

NCT06436807 2026-03-12

PMCF Study of the CE-marked Drainova® ArgentiC Catheter

Ascites, Pleural Effusion, Pleural Effusion, Malignant

NCT06282991 2026-03-10

A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled

73 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT07215026 2026-03-10

UNCOVER

Carcinoma, Non-Small-Cell Lung

NCT04328662 2026-03-04

A Study of Ninlaro in Real World Clinical Practice in China

Multiple Myeloma, Neoplasms, Plasma Cell

NCT07450157 2026-03-04

A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617

Prostatic Neoplasms

NCT06137170 2026-03-02

RegoSeq

Gastrointestinal

Colorectal Neoplasms

NCT02184416 2026-02-27

ADONIS

Carcinoma, Renal Cell

NCT04498481 2026-02-27

TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

Breast Neoplasms

NCT04894591 2026-02-27

SCLC

Small Cell Lung Carcinoma

NCT05858749 2026-02-27

A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).

Carcinoma, Renal Cell, Kidney Neoplasms

NCT05968599 2026-02-25

A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

2,731 enrolled 14 charts

Prostatic Neoplasms, Castration-Resistant

NCT07428941 2026-02-24

LegitHealth PH

Carcinoma, Basal Cell, Melanoma, Nevus, Pigmented, Skin Diseases, Urticaria, Hidradenitis Suppurativa, Keratosis, Actinic